Dr. Joshua Todd Mendelson M.D.

Media Releases

Get to know Neurologist Dr. Joshua T. Mendelson, who serves the population of New Jersey.

Dr. Joshua T. Mendelson is a highly respected and experienced physician, having been in practice for over a decade. His career in medicine began when he graduated with his Medical Degree from St. George’s University School of Medicine in New York. After medical school, Dr. Mendelson completed his internship with the Mount Sinai School of Medicine CUNY, New York, followed by his residency with Thomas Jefferson University Hospital in Pennsylvania. Driven to further his expertise and knowledge, he undertook his fellowship at the
Emory University Hospital, Atlanta, Georgia.

Dr. Mendelson is certified in neurology and clinical neurophysiology by the American Board of Psychiatry and Neurology, and has dedicated his life to delivering compassionate care. He is determined to enhance his patients’ quality of life, providing high quality, individualized care in order to ensure the most optimal results. With a passion for his work, Dr. Mendelson is noted for his expertise in neurology, clinical neurophysiology, and epilepsy. He currently practices as a Neurologist and director of the stroke service at Monmouth Medical Center and regional director of neurology at RWJBarnabas Health as well as serving as the medical director of the Epilepsy Monitoring Unit.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous systems (and their subdivisions, the autonomic and somatic nervous systems), including their coverings, blood vessels, and all effector tissue, such as muscle. Neurological practice relies heavily on the field of neuroscience, which is the scientific study of the nervous system. Neurologists may also be involved in clinical research, clinical trials, and basic or translational research.

Additional Information

Joshua T. Mendelson, MD, is a Leading Neurologist with Neurology Specialists of Monmouth County in West Long Branch, NJ

Joshua T. Mendelson, MD, is a well-versed neurologist who diagnoses and treats patients at Neurology Specialists of Monmouth County in West Long Branch, NJ. And, he is neurologist and Director of the Stroke Service at Monmouth Medical Center and the Regional Director of Neurology and Medical Director of the Epilepsy Monitoring Unit at RJW Barnabas. Dr. Mendelson is also a Clinical Assistant Professor in Neurology at Rutgers-Robert Wood Johnson School of Medicine. As a neurologist, he has dedicated training and unique experience in the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous system, including their coverings, blood vessels, and all effector tissue, such as muscle. Dr. Mendelson has an impressive professional journey that spans thirteen year. He has unrivaled expertise in all facets of neurology and has special interests in the treatment of epilepsy during pregnancy and children with febrile seizures. Dr. Mendelson has received extensive training at the Thomas Jefferson University Comprehensive Headache Center in the treatment of migraine and chronic daily headache. For more information about Dr. Joshua T. Mendelson, please visit https://www.rwjbh.org/doctors/joshua-t-mendelson-md/.

Joshua T. Mendelson, MD, attended St. George’s University School of Medicine in Grenada, West Indies, and received his medical degree in 2005. Then, he served his internship at Mount Sinai Hospital in New York. Furthermore, he conducted his residency at Thomas Jefferson University Hospital in Philadelphia, PA (2006). In addition, he completed his fellowship training in clinical neurophysiology at Emory University Hospital in Atlanta, GA (2009). Dr. Mendelson received board certification in neurology from the American Board of Psychiatry and Neurology. And, he remains at the forefront of his challenging specialty via memberships and affiliations with prestigious professional societies and associations. He completed his undergraduate education at Emory University. For more information about Dr. Joshua T. Mendelson, please visit https://www.findatopdoc.com/doctor/2431666-Joshua-Mendelson-neurologist-Philadelphia-PA-19107.

Recommended Articles

• Multiple Sclerosis Treatments Are Becoming More Effective, but Are Underfunded

  Multiple sclerosis is considered a relatively rare disease, but a recent MS guideline published by the National Institute for Health and Care Excellence stated that with more than 400,000 cases in the US alone, MS has become the leading cause of physical disability in working age adults.Although...

• What Is Latuda Used For?

  Generic Name: LurasidoneBrand Name: LatudaWhat is Latuda?Latuda (lurasidone) is an antipsychotic medication that works by changing the effects of brain chemicals. This medication is used for the treatment of schizophrenia in individuals who are 13 years old and above, and bipolar depression in...

• New Targets Found for Drug Therapy of Facioscapulohumeral Muscular Dystrophy

  One of the most common forms of muscular dystrophy is Facioscapulohumeral Muscular Dystrophy (FSHD). FSHD mainly affects the upper part of the body, causing muscular weakness in the facial muscles, shoulders, and arms.FSHD was classified as a separate form of muscular dystrophy in the late 20th...

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...

• Dogs Show Improvement After Gene Therapy for Muscular Dystrophy

  Duchenne muscular dystrophy is a progressive disease that causes body muscle weakness and atrophy as a result of a deficiency in dystrophin protein. A scientist at the University of Washington, the University of Missouri, LLC, Solid Biosciences, and NCATS have developed a gene transfer approach to...

• Organizations that Support Parkinson's Disease Patients and their Families

  Parkinson’s disease is a neuromuscular degenerative disorder that robs those afflicted of their motor functions over time. The average age of a Parkinson’s diagnosis is somewhere around the age of sixty, though at times those that are younger can also be diagnosed with the disease. Cases such as...